Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Efficacy and Safety of T+A+RAD in HCC
- Status
- UNKNOWN
- Phase
- PHASE2
A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Multimodal Deep Learning Signature for Evaluation of Response to Bevacizumab in Patient With Colorectal Cancer Liver Metastasis
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain Injury
- Status
- RECRUITING
- Phase
- PHASE2
Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- NA
Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of INCB123667 in Subjects With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
SMMART Adaptive Clinical Treatment (ACT) Trial
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3